S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
NASDAQ:LSTA

Lisata Therapeutics - LSTA News Today

$3.00
-0.08 (-2.60%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$3.00
▼
$3.10
50-Day Range
$3.03
▼
$3.75
52-Week Range
$2.36
▼
$11.85
Volume
3,286 shs
Average Volume
12,400 shs
Market Capitalization
$23.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.00
Get Lisata Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for LSTA and its competitors with MarketBeat's FREE daily newsletter.


LSTA Media Mentions By Week

LSTA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LSTA
News Sentiment
▼
1.32

0.39
▲
Average
Medical
News Sentiment

LSTA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LSTA Articles
This Week
▼
1

0
▲
LSTA Articles
Average Week

SourceHeadline
finance.yahoo.com logoLisata Therapeutics to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call on Thursday, March 30, 2023, at 4:30 p.m. Eastern Time
finance.yahoo.com - March 23 at 1:02 PM
finance.yahoo.com logoLife Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
finance.yahoo.com - March 10 at 10:15 AM
finance.yahoo.com logoLisata Therapeutics to Webcast Live at the Life Sciences Investor Forum on March 9th
finance.yahoo.com - March 6 at 10:34 AM
finance.yahoo.com logoLisata Therapeutics Announces Participation in Upcoming Conferences in February
finance.yahoo.com - February 1 at 12:57 PM
technews.tmcnet.com logoRactigen Therapeutics Announces the Appointment of Harri Järveläinen as Chief Operating Officer
technews.tmcnet.com - January 9 at 7:14 AM
finance.yahoo.com logoLisata Therapeutics, Inc. (LSTA)
finance.yahoo.com - January 9 at 7:14 AM
seekingalpha.com logoLisata Therapeutics, Inc. (LSTA) Q3 2022 Earnings Call Transcript
seekingalpha.com - November 13 at 4:38 PM
finance.yahoo.com logoLisata Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
finance.yahoo.com - November 10 at 7:50 PM
finance.yahoo.com logoLisata Therapeutics Announces Participation in Upcoming Conferences in November 2022
finance.yahoo.com - November 7 at 9:24 AM
finance.yahoo.com logoLisata Therapeutics to Host Third Quarter 2022 Financial Results Conference Call on Thursday, November 10, 2022, at 4:30 p.m. Eastern Time
finance.yahoo.com - November 3 at 9:49 AM
seekingalpha.com logoLSTA Lisata Therapeutics, Inc.
seekingalpha.com - October 27 at 7:24 PM
reuters.com logoLisata Therapeutics Inc
reuters.com - October 21 at 1:00 PM
finance.yahoo.com logoLisata Therapeutics’ Director and Scientific Founder of the CendR Platform™ Technology, Erkki Ruoslahti, M.D., Ph.D., Receives 2022 Albert Lasker Basic Medical Research Award
finance.yahoo.com - October 19 at 12:26 PM
finance.yahoo.com logoLisata Therapeutics Announces Participation in Upcoming Conferences in October 2022
finance.yahoo.com - October 19 at 12:26 PM
Get Lisata Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for LSTA and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:LSTA) was last updated on 3/24/2023 by MarketBeat.com Staff